Abbott Laboratories Share Price Wiener Boerse
Stocks
ABT
US0028241000
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Tradegate
08:41:01 02/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 96.37 EUR | -0.42% |
|
-2.02% | -8.66% |
| 01/09 | Mead Johnson wins US federal bellwether trial over preterm infant formula Enfamil | RE |
| 01/09 | Medtronic Raises Full-Year Outlook Following Fiscal First-Quarter Beat | MT |
| Market Cap | 19TCr 16TCr 15TCr 14TCr 26TCr 17,88900Cr 26TCr 1,80800Cr 70TCr 9,10000Cr 71TCr 69TCr 30,17300Cr | P/E 2026 * |
31.2x | P/E 2027 * | 24.1x |
|---|---|---|---|---|---|
| Enterprise Value | 21TCr 18TCr 17TCr 16TCr 30TCr 20,16100Cr 30TCr 2,03800Cr 79TCr 10,25500Cr 80TCr 78TCr 34,00500Cr | EV / Sales 2026 * |
4.22x | EV / Sales 2027 * | 3.83x |
| Free-Float |
86.16% | Yield 2026 * |
2.36% | Yield 2027 * | 2.52% |
Last Transcript : Abbott Laboratories
| 1 day | -0.42% | ||
| 1 week | -2.02% | ||
| Current month | +2.09% | ||
| 1 month | +6.03% | ||
| 3 months | +29.39% | ||
| 6 months | -1.88% | ||
| Current year | -8.66% |
| 1 week | 94.62 |  | 97.76 |
| 1 month | 90.5 | | 100.2 |
| Current year | 70.1 | | 109.64 |
| 1 year | 70.1 | | 116.14 |
| 3 years | 70.1 | | 134.2 |
| 5 years | 70.1 | | 134.2 |
| 10 years | 49.6 | | 134.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 31/03/2020 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 01/09/2023 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 09/12/2011 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 09/12/2011 |
Daniel Starks
BRD | Director/Board Member | 71 | 16/02/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.42% | -2.02% | - | - | 19TCr | |
| +2.57% | -2.12% | -15.05% | +10.71% | 19TCr | |
| +1.53% | +1.81% | +0.39% | +16.82% | 12TCr | |
| +1.69% | +2.63% | +14.10% | +94.61% | 6.32TCr | |
| -1.89% | -2.30% | +26.76% | +50.42% | 5.2TCr | |
| +1.60% | -0.01% | +1.09% | -30.30% | 5.1TCr | |
| -0.03% | +1.54% | +21.57% | -9.97% | 3.4TCr | |
| +1.25% | +3.85% | - | - | 3.08TCr | |
| +1.07% | -1.93% | +40.79% | -14.99% | 2.38TCr | |
| -2.97% | -4.91% | -7.98% | +11.64% | 2.34TCr | |
| Average | +0.45% | -1.66% | +10.21% | +16.12% | 6.49TCr | |
| Weighted average by Cap. | +0.88% | -2.61% | +1.93% | +19.20% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.03TCr 4.34TCr 4.08TCr 3.72TCr 6.99TCr 4,77400Cr 7.03TCr 48TCr 19TCr 2,42800Cr 19TCr 18TCr 8,05200Cr | 5.46TCr 4.71TCr 4.43TCr 4.04TCr 7.6TCr 5,18600Cr 7.64TCr 52TCr 20TCr 2,63800Cr 21TCr 20TCr 8,74800Cr |
| Net income | 623.24Cr 537.6Cr 505.7Cr 460.7Cr 866.34Cr 59TCr 871.03Cr 5.98TCr 2.33TCr 30TCr 2.34TCr 2.29TCr 1LCr | 792.44Cr 683.56Cr 643Cr 585.78Cr 1.1TCr 75TCr 1.11TCr 7.6TCr 2.96TCr 38TCr 2.98TCr 2.91TCr 1,26900Cr |
| Net Debt | 2.39TCr 2.06TCr 1.94TCr 1.77TCr 3.33TCr 2,27200Cr 3.35TCr 23TCr 8.94TCr 1,15600Cr 8.99TCr 8.79TCr 3,83200Cr | 2.1TCr 1.81TCr 1.7TCr 1.55TCr 2.91TCr 1,98900Cr 2.93TCr 20TCr 7.82TCr 1,01200Cr 7.87TCr 7.7TCr 3,35500Cr |
| Date | Price | Change |
|---|---|---|
| 28/26/28 | €96.78 | +0.67% |
| 01/26/01 | €94.62 | -0.19% |
| 31/26/31 | €94.80 | -2.05% |
| 28/26/28 | €96.78 | +0.67% |
| 27/26/27 | €96.14 | -2.61% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
- ABT Stock
Select your edition
All financial news and data tailored to specific country editions
